Louisiana Medicaid and GLP-1s
The takeaway
Louisiana Medicaid wants a signed treatment agreement before Wegovy or Zepbound, sets the Wegovy floor at age 45, and asks about bariatric surgery.
Reading the state documents
Louisiana asks for something no other state on this site asks for: a treatment agreement, completed and filed with the request, before anything is dispensed. On top of that the Wegovy pathway starts at 45 rather than 18, and if the BMI is 35 or higher the state wants to see that you were at least assessed for surgery first.
What changed, and what the document says
The paperwork before the drug
Conditions applyA separate signed document, named in the criteria, submitted alongside the authorization request.
“For initiation of therapy requests, the Tirzepatide (Zepbound®) Treatment Agreement for Louisiana Medicaid Recipients must be completed as instructed and submitted with the request form.”
Louisiana Department of Health, Louisiana Medicaid — Policy created June 2025, implementation date January 2026
Wegovy starts at 45
Conditions applyNot 18, and not the label's floor. Forty-five is the age this pathway opens at.
“The recipient is 45 years of age or older on the date of the request; AND”
Louisiana Department of Health, Louisiana Medicaid — Policy created April 2024, implemented July 2024; revised September 2024, implemented October 2024; revised November 2025, implemented March 2026
A BMI window, not a floor
Conditions applyBetween 27 and 35 you qualify on the number alone. Above 35 the state adds a step.
“The recipient has a documented Body Mass Index (BMI) of ≥ 27 kg/m2 and < 35 kg/m2;”
Louisiana Department of Health, Louisiana Medicaid — Policy created April 2024, implemented July 2024; revised September 2024, implemented October 2024; revised November 2025, implemented March 2026
Surgery gets assessed first
Conditions applyThe heavier you are, the more Louisiana wants to know you looked at an operation before a prescription.
“The recipient has a documented BMI ≥ 35 kg/m2, and documentation of evaluation or referral for bariatric surgery is provided with the request”
Louisiana Department of Health, Louisiana Medicaid — Policy created April 2024, implemented July 2024; revised September 2024, implemented October 2024; revised November 2025, implemented March 2026
Zepbound's threshold
Conditions applyA sleep study, a number, and a twelve-month recency window on the test itself.
“The patient has an established diagnosis of moderate to severe obstructive sleep apnea (OSA) with an apnea-hypopnea index (AHI) of ≥ 15 on polysomnography (PSG) within the previous 12 months (Documentation is required showing test results with corresponding date); AND”
Louisiana Department of Health, Louisiana Medicaid — Policy created June 2025, implementation date January 2026
Non-adherence to CPAP counts in the patient's favor
ContextAn unusual clause: not sticking with the machine is one of the two ways to satisfy this criterion.
“The recipient has a history of non-adherence to PAP therapy; AND”
Louisiana Department of Health, Louisiana Medicaid — Policy created June 2025, implementation date January 2026
Two chances at 5 percent
Conditions applyMiss the target once and you get three months with a written reason. Miss it twice and the criteria stop.
“For weight loss < 5%, do not approve.”
Louisiana Department of Health, Louisiana Medicaid — Policy created June 2025, implementation date January 2026
Six months to prove it
Conditions applyThat's the initiation window on the sleep-apnea route before anything is reassessed.
“Duration of approval for initiation of therapy: 6 months”
Louisiana Department of Health, Louisiana Medicaid — Policy created June 2025, implementation date January 2026
Telehealth in Louisiana
- Gala HealthPartnerCCaveatSee Gala Health pricing (opens in a new tab)$1,299a month, medication onlybrand Ozempic (semaglutide), cash priceAdditional fees not verified.
Price details
- No separate monthly fee was found in the pages reviewed. Other charges may apply.
- Brand-name Ozempic, quoted as a cash price. Gala says insurance may reduce it and does not publish what it would reduce it to.
Some providers pay us a commission when you sign up through our links, at no extra cost to you.
Which of these companies serve Louisiana?
Of the 387 companies we grade, 34 publish a list of the states they are licensed in. We checked 251 more and found no such list on any page we read; 102 we have not checked either way.
14 of those lists name Louisiana: Gala Health, Care Bare Rx, Vita Bella, TelePeptide, WePeptideRx, Ways2Well, TeleClinic, Tyde Wellness, Trimi, Rx.com, Mojoon, Peak Wellness, Allara Health, and Mixx Health & Wellness. That is a licensure claim each company makes about itself, not something we checked with a state board.
A published list is a starting point, not a guarantee. If availability decides your choice, ask before you pay and get the answer in writing.
Coverage decides what you pay before cash does. See how state Medicaid programs cover GLP-1s and what a prior-authorization denial turns on.
Sources
Source dates below are the dates printed on the documents.
- Louisiana Medicaid — Tirzepatide (Zepbound®) — Louisiana Department of Health, Louisiana Medicaid. the single row of the "Revision / Date" and "Implementation Date" table on the last page — the URL path reads 9_26_25 and the filename reads 06052025, and neither is this document's date: Policy created June 2025, implementation date January 2026.
- Louisiana Medicaid — Semaglutide (Wegovy®) — Louisiana Department of Health, Louisiana Medicaid. the whole "Revision / Date" and "Implementation Date" table on the last page, reproduced as the list it is: Policy created April 2024, implemented July 2024; revised September 2024, implemented October 2024; revised November 2025, implemented March 2026.
Nothing on this page is medical advice, and nobody here is a clinician. Coverage rules change; check the linked document before you rely on it.
If you're paying cash instead
These providers list Louisiana in their service area. Partners appear first. These are medication prices, not confirmed monthly totals. Other fees may apply; check each provider’s terms before choosing.
Some providers pay us a commission when you sign up through our links, at no extra cost to you.
| Provider | Monthly price and terms | Go to the provider |
|---|---|---|
Gala HealthCCaveat | $1,299 a month, medication only brand Ozempic (semaglutide), cash price Brand-name Ozempic, quoted as a cash price. Gala says insurance may reduce it and does not publish what it would reduce it to. Additional fees not verified. Price details
| View pricing at Gala Health (opens in a new tab)Partner |
TeleClinicAVerified | $79 a month, medication only compounded semaglutide Billed monthly, same price at every vial strength, and the product page says the rate is locked for the life of the membership. Additional fees not verified. Price details
| View pricing at TeleClinic (opens in a new tab) |
TelePeptideAVerified | $229 a month, medication only compounded semaglutide Dissolvable tablet, month-to-month. TelePeptide states on the same page that it does not sell branded GLP-1s. Additional fees not verified. Price details
| View pricing at TelePeptide (opens in a new tab) |
Care Bare RxBMinor gap | $199 a month, medication only compounded tirzepatide Both compounded drugs are quoted at the same starting figure, on one line that also puts brand names on them. Additional fees not verified. Price details
| View pricing at Care Bare Rx (opens in a new tab) |
Peak WellnessBMinor gap | $249 a month, medication only compounded semaglutide $179 covers the first month only, and the page says so on the same line. Prepaying drops it: $597 once for three months, which is $199 a month, or $990 once for six, which is $165 — but a prepaid plan is not refundable. The price is the same at every dose. Additional fees not verified. Price details
| View pricing at Peak Wellness (opens in a new tab) |
Rx.comBMinor gap | $175 a month, medication only compounded semaglutide One month, all-in: the visit, the medication at any dose, supplies and cold shipping. The $146 headline is the six-month plan, paid as $875 in one payment. Additional fees not verified. Price details
| View pricing at Rx.com (opens in a new tab) |
TrimiBMinor gap | $175 a month, medication only compounded semaglutide, billed monthly Month to month. $99 is the twelve-month rate, billed $1,188 upfront, and it's the only semaglutide figure on the homepage. Medication, supplies, provider access and shipping included. Monthly renewal is automatic; payment precedes provider review. Additional fees not verified. Price details
| View pricing at Trimi (opens in a new tab) |
MojoonCCaveat | $390 a month, medication only compounded tirzepatide Advertised at $1,000. The bottom of a $390–$490 range. Unlike the semaglutide page, this one never says what moves the price across that range. Additional fees not verified. Price details
| View pricing at Mojoon (opens in a new tab) |
Our grading method and how we verify a price explain what those letters mean and where these figures came from.